Avantor, Inc. — fact timeline

Avantor, Inc. shareholders approved Ratification of appointment of Deloitte & Touche LLP as independent registered public accounting firm for 2026 at the 2026-05-07 meeting.

“4. The stockholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026, based on the following voting results: Votes For Votes Against Abstentions Ratification of Appointment of Independent Registered Public Accounting Firm 629,271,458 8,805,313 132,376”

Avantor, Inc. shareholders approved Advisory vote on the frequency of future advisory votes on executive officer compensation at the 2026-05-07 meeting.

“3. The stockholders approved, on an advisory basis, one year as the frequency of the non-binding advisory vote to approve executive compensation, based on the following voting results: 1 Year 2 Years 3 Years Abstentions Broker Non-Votes Advisory Vote on the Frequency of Future Advisory Votes on Executive Officer Compensation 605,480,159 9,225 14,892,420 139,666 17,687,677”

Avantor, Inc. shareholders approved Advisory vote to approve 2025 named executive officer compensation at the 2026-05-07 meeting.

“2. The stockholders approved, on an advisory basis, the 2025 compensation of the Company’s named executive officers, based on the following voting results: Votes For Votes Against Abstentions Broker Non-Votes Advisory Vote on Named Executive Officer Compensation 601,462,107 18,474,344 585,019 17,687,677”

Avantor, Inc. shareholders approved Election of nine directors to serve for a one-year term expiring at the 2027 Annual Meeting of Stockholders at the 2026-05-07 meeting.

“1. The stockholders elected nine directors to serve for a one-year term expiring at the Company’s 2027 Annual Meeting of Stockholders, subject to election and qualification of their successors, based on the following voting results: Votes For Votes Against Abstentions Broker Non-Votes Nominee Simon Dingemans 597,767,916 2,626,150 20,127,404 17,687,677 Emmanuel Ligner 588,992,737 11,392,819 20,135,914 17,687,677 Gregory Lucier 585,865,815 14,527,528 20,128,127 17,687,677 Louise Makin 593,540,559 26,641,131 339,780 17,687,677 Joseph Massaro 590,921,914 29,353,354 246,202 17,687,677 Sanjeev Mehra 596,961,853 3,421,597 20,138,020 17,687,677 Mala Murthy 594,916,679 25,361,252 243,539 17,687,677 Michael Severino 588,864,758 31,415,688 241,024 17,687,677 Gregory Summe 522,018,929 78,326,277 20,176,264 17,687,677”

Avantor, Inc. reported first fiscal quarter ended March 31, 2026 results: revenue $1,581.4 million, net income $43.3 million, EPS $0.06. Guidance reaffirmed.

“Act of 1933, except as expressly set forth by specific reference in such a filing. --- EX-99.1 (EX-99.1) --- Avantor® Reports First Quarter 2026 Results • Net sales of $1,581 million • Net income of $43 million; Adjusted EBITDA of $219 million • Diluted GAAP EPS of $0.06; adjusted EPS of $0.17 • Operating cash flow of $59 million; free cash flow of $25”

Avantor, Inc. incurred term loan of €550 million with Goldman Sachs Bank USA, as administrative agent and collateral agent at 2.50% plus the benchmark rate maturing October 9, 2032.

“(iii) establishes a new €550 million tranche of Incremental B-6 Euro Term Loans (the “TLB” and, together with the RCF and the TLA, the “New Credit Facilities”).”

Avantor, Inc. incurred term loan of €400 million with Goldman Sachs Bank USA, as administrative agent and collateral agent maturing October 9, 2030.

“(ii) establishes a new €400 million tranche of Incremental Euro Term A Loans (the “TLA”);”

Avantor, Inc. incurred revolving credit of $1.4 billion with Goldman Sachs Bank USA, as administrative agent and collateral agent maturing October 9, 2030.

“(i) provides for replacement revolving credit commitments in the amount of $975 million and establishes an additional $425 million of incremental revolving credit commitments, resulting in an aggregate of $1.4 billion in revolving credit commitments under the Amended Credit Agreement (the “RCF”);”

Michael Stubblefield departed as Director, President and Chief Executive Officer at Avantor, Inc..

“Michael Stubblefield and Avantor, Inc. (the “Company”) agreed to initiate a leadership transition and Mr. Stubblefield agreed to step down from his role as Director, President and Chief Executive Officer of the Company, effective upon the appointment of his successor.”

Jim Bramwell departed as Executive Vice President, Sales and Customer Excellence at Avantor, Inc..

“On January 6, 2025, Avantor, Inc. (the “Company”) was notified by Jim Bramwell, its Executive Vice President, Sales and Customer Excellence, of his intention to retire from the Company on or around June 30, 2025, and pursue a full-time service opportunity within his faith.”

Dame Louise Makin DBE was elected as director at Avantor, Inc..

“On November 4, 2024, the Board of Directors (the “Board”) of Avantor, Inc. (the “Company”), upon the recommendation of its Nominating and Governance Committee, elected Dame Louise Makin DBE as a director with an initial term expiring on the date of the Company’s 2025 Annual Meeting of Stockholders.”

Frederic Vanderhaegen departed as Executive Vice President, Europe at Avantor, Inc..

“the Company and Frederic Vanderhaegen, the Company’s former Executive Vice President, Europe, and a named executive officer in the Company’s definitive proxy statement on Schedule 14A filed on March 29, 2024, agreed that Mr. Vanderhaegen would depart from the Company on June 30, 2024.”

Randy Stone departed as Executive Vice President, Laboratory Solutions at Avantor, Inc..

“On June 21, 2024, Avantor, Inc. (the “Company”) announced that Randy Stone, who had served as the Executive Vice President, Laboratory Solutions, would be leaving the Company effective June 30, 2024.”

Avantor, Inc.: Amended certificate of incorporation to provide for officer exculpation as permitted by Delaware law and make other non-substantive changes (effective 2024-05-09).

“the Amended and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware, and the Amended and Restated Certificate of Incorporation became effective on May 9, 2024.”

Avantor, Inc. shareholders approved Advisory approval of 2023 named executive officer compensation at the 2024-05-09 meeting.

“The stockholders approved, on an advisory basis, the 2023 compensation of the Company’s named executive officers, based on the following voting results:”

Avantor, Inc. shareholders approved Ratify appointment of Deloitte & Touche LLP as independent registered public accounting firm for 2024 at the 2024-05-09 meeting.

“The stockholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2024, based on the following voting results:”

Avantor, Inc. shareholders approved Approve amendments to the Certificate of Incorporation to provide for officer exculpation and other non-substantive changes at the 2024-05-09 meeting.

“The stockholders approved amendments to the Certificate of Incorporation to provide for officer exculpation in accordance with changes to Delaware law, and to make certain other immaterial changes, based on the following voting results:”

Avantor, Inc. shareholders approved Election of nine directors at the 2024-05-09 meeting.

“The stockholders elected nine directors to serve for a one-year term expiring at the Company’s 2025 Annual Meeting of Stockholders, subject to election and qualification of their successors, based on the following voting results:”

Avantor, Inc. reported first fiscal quarter ended March 31, 2024 results: revenue $1.68 billion, net income $60.4 million, EPS $0.09. Guidance reaffirmed.

“Act of 1933, except as expressly set forth by specific reference in such a filing. --- EX-99.1 (EX-99.1) --- Avantor® Reports First Quarter 2024 Results • Net sales of $1.68 billion, decrease of 5.6%; organic decline of 6.3% • Net income of $60 million; Adjusted EBITDA of $283 million • Diluted GAAP EPS of $0.09; adjusted EPS of $0.22 • Operating cash flow”

Avantor, Inc. incurred term loan of $772,396,875.00 with Goldman Sachs Bank USA at SOFR plus a spread of 2.00% per annum maturing November 6, 2027.

“the Borrower obtained a $772,396,875.00 tranche of senior secured U.S. dollar term loans (the “Incremental B-6 Dollar Term Loans”).”

Avantor, Inc. amended Amendment No. 12 with Goldman Sachs Bank USA, as administrative agent and collateral agent valued at $772,396,875.00 (effective 2024-04-02).

“On April 2, 2024 (the “Effective Date”), Avantor, Inc.’s (the “Company”) wholly owned subsidiary, Avantor Funding, Inc. (the “Borrower”), entered into Amendment No. 12 (the “Credit Agreement Amendment”) to Credit Agreement, dated as of November 21, 2017”

Avantor, Inc.: Amended and restated bylaws to update director nomination and proxy solicitation rules, remove stockholder list requirement, clarify indemnification, and make ministerial changes (effective 2024-02-23).

“The Board of Directors (the “Board”) of Avantor, Inc. (the “Company”) adopted the fourth amended and restated bylaws of the Company (the “Bylaws”) on February 23, 2024.”

Avantor, Inc. reported the year ended December 31, 2023 results: revenue $6.97 billion, net income $321.1 million, EPS $0.47.

“Full Year 2023 • Net sales of $6.97 billion, decrease of 7.3%; core organic decline of 5.2% • Net income of $321.1 million; Adjusted EBITDA of $1,309.1 million • Diluted GAAP EPS of $0.47; adjusted EPS of $1.06”

Avantor, Inc. reported the quarter ended December 31, 2023 results: revenue $1.72 billion, net income $98.5 million, EPS $0.15.

“Fourth Quarter 2023 • Net sales of $1.72 billion, decrease of 4.0%; core organic decline of 4.8% • Net income of $98.5 million; Adjusted EBITDA of $302.1 million • Diluted GAAP EPS of $0.15; adjusted EPS of $0.25”

Frederic Vanderhaegen departed as Executive Vice President, Europe at Avantor, Inc..

“on December 1, 2023, the Company informed each of Sheri Lewis, the Company’s Executive Vice President, Global Supply Chain, and Frederic Vanderhaegen, the Company’s Executive Vice President, Europe, that each would depart from the Company in 2024 after supporting the Company’s transition to its new operating model.”

Sheri Lewis departed as Executive Vice President, Global Supply Chain at Avantor, Inc..

“on December 1, 2023, the Company informed each of Sheri Lewis, the Company’s Executive Vice President, Global Supply Chain, and Frederic Vanderhaegen, the Company’s Executive Vice President, Europe, that each would depart from the Company in 2024 after supporting the Company’s transition to its new operating model.”

Avantor, Inc. reported the third quarter ended September 30, 2023 results: revenue $1.72 billion, net income $108.4 million, EPS $0.16.

“Act of 1933, except as expressly set forth by specific reference in such a filing. --- EX-99.1 (EX-99.1) --- Avantor® Reports Third Quarter 2023 Results • Net sales of $1.72 billion, decrease of 7.3%; core organic decline of 7.9% • Net income of $108.4 million; Adjusted EBITDA of $317.8 million • Diluted GAAP EPS of $0.16; adjusted EPS of $0.25 • Operating”

Gerard Brophy departed as Executive Vice President, Biopharma Production at Avantor, Inc..

“On September 26, 2023, Avantor, Inc. (the “Company”) announced that Dr. Gerard Brophy, the Company’s Executive Vice President, Biopharma Production and a named executive officer in the Company’s definitive proxy statement on Schedule 14A filed on March 31, 2023, will be stepping down from that position on October 2, 2023, and retiring from the Company effective February 29, 2024.”

Avantor, Inc. reported the second quarter ended June 30, 2023 results: revenue $1.74 billion, net income ($7.3) million, EPS ($0.01).

“Act of 1933, except as expressly set forth by specific reference in such a filing. --- EX-99.1 (EX-99.1) --- Avantor® Reports Second Quarter 2023 Results • Net sales of $1.74 billion, decrease of 8.7%; core organic decline of 6.5% • Net income of ($7.3) million; Adjusted EBITDA of $343.0 million • Diluted GAAP EPS of ($0.01); adjusted EPS of $0.28 • Operating”

Thomas Szlosek resigned as Executive Vice President and Chief Financial Officer at Avantor, Inc..

“the Company’s current Executive Vice President and Chief Financial Officer, Thomas Szlosek, whose resignation was previously announced, has agreed to continue in his position through August 4, 2023.”

R. Brent Jones was appointed as Executive Vice President and Chief Financial Officer at Avantor, Inc..

“On July 13, 2023, Avantor, Inc. (the “Company”), announced the appointment of R. Brent Jones as Executive Vice President and Chief Financial Officer, effective as of August 7, 2023.”

Avantor, Inc. incurred revolving credit of $975 million with Goldman Sachs Bank USA, as administrative agent and collateral agent at same as the interest rate and commitment fees in respect of the Existing Revolvi maturing June 29, 2028.

“sentence, the aggregate amount of New Revolving Commitments under the Credit Agreement (which constitute all of the revolving commitments under the Credit Agreement) is $975 million. The final stated maturity of the New Revolving Commitments is June 29, 2028, subject to an earlier springing maturity to (i) with respect to the Incremental B-5 Dollar Term”

Avantor, Inc. amended Amendment No. 11 to Credit Agreement dated as of November 21, 2017 with Goldman Sachs Bank USA valued at Obtained $515 million of refinancing revolving credit commitments and $460 million increase, resulti (effective 2023-06-29).

“Item 1.01. Entry into a Material Definitive Agreement. On June 29, 2023 (the “Effective Date”), Avantor, Inc.’s (the “Company”) wholly owned subsidiary, Avantor Funding, Inc. (“Avantor Funding”), entered into Amendment No. 11 (the “Amendment”) to Credit Agreement, dated as of November 21, 2017 (as amended by Amendment No. 1 to Credit Agreement, dated as of November 27, 2018, Amendment No. 2 to Credit Agreement, dated as of June 18, 2019, Amendment No. 3 to Credit Agreement, dated as of January 24, 2020, Amendment No. 4 to Credit Agreement, dated as of July 14, 2020, Amendment No. 5 to Credit Agreement, dated as of November 6, 2020, Amendment No. 6 to Credit Agreement, dated as of June 10, 2021, Amendment No. 7 to Credit Agreement, dated as of July 7, 2021, Amendment No. 8 to Credit Agreement, dated as of November 1, 2021, Amendment No. 9 to Credit Agreement, dated as of April 7, 2022, Amendment No. 10 to Credit Agreement, dated as of March 17, 2023, and as further amended, restated, ex”

Thomas A. Szlosek resigned as Executive Vice President and Chief Financial Officer at Avantor, Inc..

“On May 9, 2023, Mr. Thomas A. Szlosek notified the Company of his decision to resign as the Company’s Executive Vice President and Chief Financial Officer (“CFO”), effective as of August 2, 2023, to join a company outside the life sciences industry.”

Avantor, Inc. shareholders approved Advisory vote on named executive officer compensation at the 2023-05-11 meeting.

“3. The stockholders approved, on an advisory basis, the 2022 compensation of the Company’s named executive officers, based on the following voting results:”

Avantor, Inc. shareholders approved Ratification of appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2023 at the 2023-05-11 meeting.

“2. The stockholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2023, based on the following voting results:”

Avantor, Inc. shareholders approved Election of ten directors to serve for a one-year term at the 2023-05-11 meeting.

“1. The stockholders elected ten directors to serve for a one-year term expiring at the Company’s 2024 Annual Meeting of Stockholders, subject to election and qualification of their successors, based on the following voting results:”

Avantor, Inc. reported first quarter ended March 31, 2023 results: revenue $1.78 billion, net income $121.5 million, EPS $0.18.

“• Net sales of $1.78 billion, decrease of 8.7%; core organic decline of 1.8% • Net income of $121.5 million; Adjusted EBITDA of $346.2 million • Diluted GAAP EPS of $0.18; adjusted EPS of $0.29”

Avantor, Inc. reported the year ended December 31, 2022 results: revenue $7.51 billion, net income $686.5 million, EPS $1.01.

“For the full-year ended December 31, 2022, net sales were $7.51 billion, an increase of 1.7% compared to 2021. Foreign currency translation had an unfavorable impact of 4.3% with M&A adding 3.6%, resulting in organic sales growth of 2.4% and core organic sales growth of 6.0% (excluding COVID-19 headwinds). Net income increased to $686.5 million from $572.6 million in 2021 and adjusted net income was up 10.6% from the comparable prior period, excluding foreign exchange headwinds. Adjusted EBITDA was $1,570.7 million, an increase of 11.8% from 2021, excluding foreign exchange headwinds. Adjusted EBITDA margin expanded by approximately 110 basis points to 20.9%. Diluted earnings per share on a GAAP basis for 2022 was $1.01, while adjusted EPS was $1.41.”

Avantor, Inc. reported the quarter ended December 31, 2022 results: revenue $1.80 billion, net income $141.7 million, EPS $0.21.

“For the three months ended December 31, 2022, net sales were $1.80 billion, a decrease of 5.9% compared to the fourth quarter of 2021. Foreign currency translation had an unfavorable impact of 4.5% with M&A adding 0.7%, resulting in an organic sales decline of 2.1% and core organic sales growth of 2.7% (excluding COVID-19 headwinds). Net income increased to $141.7 million from $94.0 million in the fourth quarter of 2021 and adjusted net income was $214.0 million as compared to $229.2 million in the comparable prior period. Adjusted EBITDA was $359.5 million and adjusted EBITDA margin expanded by more than 60 basis points to 20.0%. Diluted earnings per share on a GAAP basis was $0.21, while adjusted EPS was $0.32.”

Matt Holt retired as Director at Avantor, Inc..

“Effective as of November 16, 2022, Matt Holt retired from the Board of Directors (the “Board”) of Avantor, Inc. (the “Company”).”

Avantor, Inc. reported for the full year results: EPS $1.38 to $1.40 of adjusted EPS.

“We now expect to deliver 2.5% - 3.0% organic growth (6.0% - 6.5% excluding COVID-19 headwinds) and $1.38 to $1.40 of adjusted EPS for the full year.”

Avantor, Inc. reported for the quarter ended September 30, 2022 results: revenue $1.86 billion, net income $167.0 million, EPS $0.25.

“Net sales of $1.86 billion, increase of 1.2%; core organic net sales growth of 7.8% • Net income of $167.0 million; Adjusted EBITDA of $384.0 million • Diluted GAAP EPS of $0.25; adjusted EPS of $0.34”

Rajiv Gupta departed as Chairman of the Board at Avantor, Inc..

“On February 10, 2022, Rajiv Gupta informed Avantor, Inc. (the “Company”) that he will not stand for re-election to the Company’s Board of Directors (the “Board”) at the Company’s 2022 annual meeting of stockholders (the “2022 Annual Meeting”).”

Joseph Massaro was appointed as Class II Director at Avantor, Inc..

“On November 8, 2021, the Board, upon the recommendation of its Nominating and Governance Committee, appointed Joseph Massaro as a Class II director with an initial term expiring at the Company’s 2022 Annual Meeting of Stockholders.”

Mala Murthy was appointed as Class I director at Avantor, Inc..

“On October 28, 2021, the Board, upon the recommendation of its Nominating and Governance Committee, appointed Mala Murthy as a Class I director with an initial term expiring at the Company’s 2022 Annual Meeting of Stockholders.”

John Carethers, M.D. was appointed as Director at Avantor, Inc..

“On July 15, 2021, the Board, upon the recommendation of its Nominating and Governance Committee, appointed John Carethers, M.D. as a Class III director with an initial term expiring at the Company’s 2022 Annual Meeting of Stockholders.”